Vontobel Holding’s Corbus Pharmaceuticals CRBP Stock Holding History

Vontobel Holding’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-685	Closed	-$26K	–	1015
2020 Q4	$26K	Buy	+685	New	+$25.6K	﹤0.01%	957

Other funds holding CRBP

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Vontobel Holding's CRBP Position: Q1 2021 in Review

Vontobel Holding sold out of Corbus Pharmaceuticals (CRBP) in Q1 2021, closing a stake of 685 shares — an estimated $26K sold.

Vontobel Holding first reported a position in CRBP in Q4 2020 and held it in 1 quarter. The position peaked at $26K in Q4 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2021.

Vontobel Holding reported no remaining Corbus Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Vontobel Holding sold 685 Corbus Pharmaceuticals shares in Q1 2021, an estimated $26K.
Vontobel Holding first reported a position in Corbus Pharmaceuticals in Q4 2020 and held it in 1 quarter.
Vontobel Holding's Corbus Pharmaceuticals position peaked at $26K in Q4 2020.
107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2021.

Based on Vontobel Holding's 13F filing for Q1 2021, filed 11 May 2021.